RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE | RA CAPITAL MANAGEMENT L.P. | 1,961,863 3.400% | -16,038 (-0.81%) | Filing |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | Apogee Therapeutics, Inc. APGE | RA CAPITAL MANAGEMENT L.P. | 1,977,901 5.300% | 1,977,901 (New Position) | Filing |